Adamis Pharmaceuticals Corp. (NASDAQ:ADMP) shares traded up 11.5% during mid-day trading on Tuesday . The stock traded as high as $3.00 and last traded at $3.00, with a volume of 1,110,579 shares. The stock had previously closed at $2.69.

Separately, Maxim Group reiterated a “buy” rating on shares of Adamis Pharmaceuticals Corp. in a research note on Tuesday, May 10th.

The stock’s market cap is $61.40 million. The stock has a 50-day moving average of $2.88 and a 200 day moving average of $5.30.

Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.